# Sanofi Decides to Stop Studies of Nurix-Partnered Experimental Drug

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/48968
Published: 2026-11-05T02:33:37.000Z
Updated: 2026-11-05T02:33:37.000Z
Section: Business

> Nurix Therapeutics shares extended losses from after Tuesday’s market close into Wednesday premarket trading.

Nurix Therapeutics said Tuesday that its partner Sanofi had decided to stop studies of an experimental inflammatory disease therapy.

NRIX shares entered Wednesday’s premarket session with losses from after the market closed Tuesday still in place.